The divergent effect of insulin-like growth factor binding protein (IGFBP) - 1 On IGF-induced steroidogenesis in bovine adrenocortical cells is not due to its phosphorylation status

Experimental and Clinical Endocrinology and Diabetes

Volumn 115, Issue 4, 2007, Pages 232-239

  Fottner, C ^a   Spottl G ^b   Weber, M M ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Adrenal; IGF binding protein 1; IGF I; IGF II; Insulin like growth factor; Phosphorylation

Indexed keywords

HYDROCORTISONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2;

ADRENAL CORTEX CELL; ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; HYDROCORTISONE RELEASE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; STEROIDOGENESIS;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; CATTLE; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HYDROCORTISONE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; KINETICS; PHOSPHORYLATION; SOMATOMEDINS;

EID: 34248589350     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970576     Document Type: Article

References (41)

1. Arafah BM. Insulin-like growth factor-I receptors in the rat adrenal. J Lab Clin Med 1991; 118: 531-537
2. Bankowski E, Sobolewski K, Palka J, Jaworski S. Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis. Clin Chem Lab Med 2004; 42: 175-181
3. Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 2003; 14: 176-181
4. Busby WH, Klapper DG, Clemmons DR. Purification of a 31,000-Dalton Insulin-like growth factor binding protein from human amniotic fluid. J Biol Chem 1988; 263: 14203-14210
5. Clemmons DR. Role of post translational modifications in modifying the biologic activity of insulin-like growth factor binding proteins. In: LeRoith D, Raiza MK (eds.). Current Directions in Insulin-like growth factor Research. New York, Plenum Press, 1994; 245-253
6. Conover CA, Clarkson JT, Bale LK. Insulin-like growth factor II enhancement of human fibroblast growth via a non-receptor mediated mechanism. Endocrinology 1994; 135: 76-82
7. Coverly JA, Baxter RC. Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol 1997; 128: 1-5
8. Ferry RJ, Cerri RW, Cohen P. 1999 Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 1999; 51: 53-67
9. Firth SM, Baxter RC. Cellular actions of Insulin-like grpwth factor binding proteins. Endocrine Rev 2002; 23: 824-854
10. Fottner C, Engelhardt D, Elmlinger MW, Weber MM. Identification and Characterization of Insulin-like growth factor binding protein -expression and -secretion by adult human adrenocortical cells: Regulation by Insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH). J Endocrino 2001; 168: 465-474
11. Fottner C, Engelhardt D, Weber MM. Regulation of steroidogenesis by Insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I, and more potently IGF-II, preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins. J Endocrinol 1998; 158: 409-417
12. Fottner C, Engelhardt D, Weber MM. Characterization of Insulin-like growth factor binding proteins (IGFBPs) secreted by adult bovine adrenocortical cells in primary culture: Regulation by Insulin-like growth factors and Adrenocorticotropin (ACTH). Horm Metab Res 1999; 31: 203-208
13. Gibson JM, Aplin JD, White A, Westwood M. Regulation of IGF bioavailability in pregnancy. Mol Hum Reprod 2001; 7: 79-87
14. Gibson JM, Westwood M, Siddal SK, Shaik T, White A. IGFBP-1 is proteolysed by decidual cell medium, hepG2-medium and amniotic fluid. 4th International Symposium on Insulin-like growth factors, Tokyo, 1997; C-06
15. Han VKM, Lu F, Bassett N, Yang KP, Delhanty PJD, Challis JRG. Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF-II. Endocrinology 1992; 131: 3100-3109
16. Han VKM, Lund PK, Lee DC, D'Ércole AJ. Expression of somatomedin/ insulin-like growth factor messenger RNAs in the human fetus: identification, charaterization and tissue distribution. J Clin Endocrinol Metab 1988; 66: 422-429
17. Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast α5ß1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res 1998; 8: 21-31
18. Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation. J Clin Endocrinol Metab 2001; 86: 2060-2064
19. Jones LI, Clemmons DR. Insulin-like growth-factors and their Binding proteins: Biological actions. Endocrine Rev 1995; 16: 3-34
20. Jones LI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phoshorylation of Insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo. Proc Natl Acad Sci USA 1991; 18: 7481-7485
21. Jyung RW, Mustoe JA, Busby WH Jr, Clemmons DR. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery 1994; 115: 223-229
22. Koistinen R, Angervo M, Leinonen P, Hakala T, Seppälä M. Phosphorylation of insulin-like growth factor bindin protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chem Acta 1993; 215: 189-199
23. Kratz G, Lake M, Ljungström K, Forsberg G, Haegerstrand, Gidlund M. 1992 Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-i but not IGF-II-induced cell proliferation. Exp Cell Res 1992; 201: 381-385
24. Lang CH, Vary TC, Frost RA. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 2003; 144: 3922-3933
25. Lee PDK, Conover CA, Powell RD. Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 1993; 204: 4-29
26. Lee PDK, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1 - Recent findings and new directions. Proc Soc Exp Biol Med 1997; 216: 319-357
27. Maile LA, Holly JMP. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm & IGF Res 1999; 9: 85-95
28. Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland. J Clin Endocrinol Metab 1993; 76: 968-975
29. Naaman E, Chatelain P, Saez JM, Durand P. In vitro effect of insulin and insulin-like growth factor-I on cell multiplication and adrenocorticotropin responsiveness of fetal adrenal cells. Biol Reprod 1989; 40: 570-577
30. Nakamura M, Miyamoto S, Maeda H. Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun 2005; 333: 1011-1016
31. Penhoat A, Chatelain PG, Jaillard C, Saez JM. Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function. Endocrinology 1988; 122: 2518-2526
32. Penhoat A, Jaillard C, Saez JM. Synergistic effects of corticotropin and insulin-like growth factor I on corticotropin receptors and corticotropin responsiveness in cultured bovine adrenocortical cells. Biochem Biophys Res Commun 1989; 165: 355-359
33. Peterkofsky B, Gosiewska A, Wilson S, Kim YR. Phosphorylation of rat insulin-like growth factor binding protein-1 does bot affect its biological properties. Arch Biochem Biophys 1998; 357: 101-110
34. Pham-Huu-Trung MT, Villette JM, Bogyo A, Duclos JM, Fiet J, Binoux M. Effects of insulin-like growth factor-I (IGF-I) on enzymatic activity in human adrenocortical cells: Interactions with ACTH. J Steroid Biochem Mol Biol 1991; 39: 903-909
35. Siddals KW, Westwood M, Gibson JM, White A. IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. J Endocrinol 2002; 174: 289-297
36. Weber MM, Auernhammer CJ, Kiess W, Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands. Eur J Endocrinol 1997; 136: 296-303
37. Weber MM, Fottner C, Engelhardt D. Adrenocortical and adrenomedullary cells. In: Endocrine Cell Culture, Ed.: S. Bidey, Cambridge University Press 1998; 75-93
38. Weber MM, Kiess W, Beikler T, Simmler P, Reichel M, Adelmann B, Kessler U, Engelhardt D. Identification and characterization of insulin-like growth factor I (IGF-I) and IGF-II/mannose-6-phosphate (IGF-II/M6P) receptors in bovine adrenal cells. Eur J Endocrinol 1994; 130: 265-270
39. Weber MM, Simmler P, Fottner C, Engelhardt D. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating Cortisol secretion from cultured bovine adrenocortical cells: Interaction with the IGF-I receptor and IGF-binding proteins. Endocrinology 1995; 136: 3714-3720
40. Westwood M, Gibson JM, White A. Purification and characterization of the Insulin-like growth factor-binding protein-1 phosphoform found in normal plasma. Endocrinology 1997; 138: 1130-1136
41. Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A, White A. Hormonal regulation of circulating insulin-luke growth factor binding protein-1 phosphorylation status. J Clin Endocrinol Metab 1995; 80: 3520-3527